Ebola Drug Trial Is Halted for Lack of Patients

Sunday, February 1, 2015 - 22:20 in Health & Medicine

Chimerix, a pharmaceutical company, had sent enough of its antiviral drug to Liberia for 140 patients, but less than 10 had shown up, underscoring the falloff of Ebola cases in Western Africa.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net